Bioceres Crop Solutions Corp. filed its annual report on Form 20-F with the U.S. Securities and Exchange Commission on October 30, 2026, covering the fiscal year ended June 30, 2026.

Key Highlights

  • Shares outstanding: 63,815,891 ordinary shares were issued and outstanding as of June 30, 2026.
  • Exchange listing: Ordinary shares, par value US$0.0001 per share, trade on NASDAQ:BIOX.
  • Filer status: The company is classified as an accelerated filer and is not an emerging growth company.
  • Accounting standards: Financial statements are prepared under International Financial Reporting Standards (IFRS) as issued by the IASB, with U.S. dollars as the presentation currency.
  • New accounting amendment: The company applied Amendments to IAS 21 - Lack of Exchangeability for the first time in the annual reporting period commencing July 1, 2025.
  • Internal controls: The registered public accounting firm filed an attestation report on management's assessment of internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act.

Bioceres Crop Solutions Annual Disclosure for Fiscal Year 2026

Bioceres Crop Solutions Corp., a Cayman Islands-incorporated company with principal executive offices in Rosario, Province of Santa Fe, Argentina, filed its Form 20-F annual report with the SEC on October 30, 2026. The filing covers the fiscal year ended June 30, 2026 and includes audited consolidated financial statements for the years ended June 30, 2026, 2025, and 2024, as well as consolidated statements of financial position data as of June 30, 2026 and 2025, according to the filing.

The company, which operates in the crop solutions sector and trades on the Nasdaq Stock Market LLC under the ticker symbol BIOX, reported 63,815,891 ordinary shares issued and outstanding as of the close of the fiscal year. The registrant's ordinary shares carry a par value of US$0.0001 per share, as disclosed on the cover page. The filing also notes that the company is subject to reporting obligations under Section 13 or 15(d) of the Securities Exchange Act of 1934 and confirmed it has filed all required reports during the preceding 12 months.

According to the filing, consolidated financial data is prepared in accordance with IFRS as issued by the IASB, with U.S. dollars as the presentation currency. For the annual reporting period commencing July 1, 2025, the company applied Amendments to IAS 21 regarding lack of exchangeability for the first time. The filing covers a broad range of disclosures including operating results, liquidity and capital resources, risk factors, director and senior management information, major shareholders, related party transactions, and cybersecurity, among other items enumerated in the table of contents.

What Was Disclosed

Bioceres Crop Solutions Corp. submitted its Form 20-F annual report for the fiscal year ended June 30, 2026, disclosing 63,815,891 ordinary shares outstanding, accelerated filer status, IFRS-based financial statements, and first-time adoption of Amendments to IAS 21.